Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: Magnetic resonance imaging versus echocardiography

American Heart Journal

Volumn 132, Issue 5, 1996, Pages 1020-1027

  Posma, Jan L ^a   Blanksma, Paul K ^a   Van Der Wall, Ernst E ^b   Hamer, Hans P M ^a   Mooyaart, Eduard L ^a   Lie, Kong I ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SCORING SYSTEM;

EID: 0029807809     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90016-2     Document Type: Article

References (30)

1. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide-angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 1981;48:418-28.
2. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, et al. Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy [review]. Prog Cardiovasc Dis 1985;28:1-83.
3. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990;15:1521-6.
4. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995; 92:1680-92.
5. Dong SJ, MacGregor JH, Crawley AP, McVeigh E, Belenkie I, Smith ER, et al. Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy: a three-dimensional tagged magnetic resonance imaging study. Circulation 1994;90:1200-9.
6. Hayashida W, Kumada T, Kohno P, Noda M, Ishikawa N, Kojima J, et al. Left ventricular regional relaxation and its nonuniformity in hypertrophic nonobstructive cardiomyopathy. Circulation 1991;84:1496-504,
7. Lechin M, Quinones MA, Omran A, Hill R, Yu Q-T, Rakowski H, et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995;92:1808-12.
8. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Circulation 1994;90:2731-42.
9. Sardanelli F, Molinari G, Petillo A, Ottonello C, Parodi RC, Masperone MA, et al. MRI in hypertrophic cardiomyopathy: a morpriofunctional study. J Comput Assist Tomogr 1993;17:862-72.
10. Higgins CB, Byrd BF, Stark D, McNamara M, Lanzer P, Lipton MJ, et al. Magnetic resonance imaging in hypertrophic cardiomyopathy. Am J Cardiol 1985;55:1121-6.
11. Park JH, Kim YM, Chung JW, Park YB, Han JK, Han MC. MR imaging of hypertrophic cardiomyopathy. Radiology 1992;185:441-6.
12. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 1979;43:1242-4.
13. Standardization of cardiac tomographic imaging. ACC/AHA/SNM policy statement. J Am Coll Cardiol 1992;20:255-6.
14. Dinsmore RE, Wismer GL, Levine RA, Okada RD, Brady TJ. Magnetic resonance imaging of the heart: position and gradient angle selection for optimal imaging planes. AJR Am J Roentgenol 1984;143:1135-42.
15. Dinsmore RE. MRI determination of cardiac dimensions. In: Van der Wall EE, De Roos A, editors. Magnetic resonance imaging in coronary artery disease. Dordrecht: Kluwer Academic Publishers, 1991:97-111.
16. Henry WL, DeMaria AN, Gramiak R, King DL, Kisslo JA, Popp RL, et al. Report of the American Society of Echocardiography Committee on nomenclature and standards in two-dimensional echocardiography. Circulation 1980;62:212-7.
17. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy. Am J Cardiol 1987;60:123-9.
18. Casolo GC, Trotta F, Rostagno C, Poggesi L, Galanti G, Masotti G, et al. Detection of apical hypertrophic cardiomyopathy by magnetic resonance imaging. Am Heart J 1989;117:468-72.
19. Suzuki J, Watanabe F, Takenaka K, Amano K, Amano W, Igarashi T, et al. New subtype of apical hypertrophic cardiomyopathy identified with nuclear magnetic resonance imaging as an underlying cause of markedly inverted T waves. J Am Coll Cardiol 1993;22:1175-81.
20. Semelka RC, Tomei E, Wagner S, Mayo J, Caputo G, O'Sullivan M, et al. Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologicallly abnormal left ventricle. Am Heart J 1990;119:1367-73.
21. Liu P, Wilansky S, Poon P, Henkelman M, Levitt M, Thompson R, et al. Myocardial mass quantitation by magnetic resonance imaging in hypertrophic cardiomyopathy [abstract]. Circulation 1986;74:226.
22. Allison JD, Flickinger FW, Wright JC, Falls DG III, Prisant LM, Von-Dohlen TW, et al. Measurement of left ventricular mass in hypertrophic cardiomyopathy using MRI: comparison with echocardiography. Magn Reson Imaging 1993;11:329-34.
23. Been M, Kean D, Smith MA, Douglas RHB, Best JJK, Muir AL. Nuclear magnetic resonance in hypertrophic cardiomyopathy. Br Heart J 1985;54:48-52.
24. Schneider R, Koehler D, Berghoefer G, Paeprer H, Felix R, Thormann I, et al. Recognition of regional hypertrophy in hypertrophic cardiomyopathy using gated magnetic resonance tomography: comparison with hypertensives and normal volunteers. Z Kardiol 1985;74:144-51.
25. Reichek N, Helak J, Plappert T, St. John Sutton M, Weber KT. Anatomic validation of left ventricular mass estimates from two-dimensional echocardiography: initial results. Circulation 1983;67;348-52.
26. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes: insights into methods for distinguishing athlethe's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995;91:1596-601.
27. Vacek JL, Davis WR, Bellinger RL, McKiernan TL. Apical hypertrophic cardiomyopathy in American patients. Am Heart J 1984;108:1501-6.
28. Rebergen SA, Doornbos J, van der Wall EE, de Roos A. MR measurement of velocity and flow: techniques, validation, and clinical applications. Am Heart J 1993;126:1439-56.
29. Maier SE, Fischer SE, McKinnon GC, Hess OM, Krayenbuehl HP, Boesiger P. Evaluation of left ventricular segmental wall motion in hypertrophic cardiomyopathy with myocardial tagging. Circulation 1992;86:1918-26.
30. De Roos A, Doornbos J, Luyten PR, Oosterwaal LJ, van der Wall EE, den Hollander J. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy. J Magn Reson Imaging 1992;2:711-5.